JPRN-UMIN000012099
Completed
Phase 2
Randomized Phase II Study of 5-fluorouracil Hepatic Arterial Infusion With or Without Antineoplastons as an Adjuvant Therapy After Hepatectomy for Liver Metastases from Colorectal Cancer - Randomized Phase II Study of Antineoplastons as an Adjuvant Therapy for Liver Metastases from Colorectal Cancer
Kurume University School of Medicine0 sites50 target enrollmentOctober 22, 2013
Conditionsiver Metastases from Colorectal Cancer
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- iver Metastases from Colorectal Cancer
- Sponsor
- Kurume University School of Medicine
- Enrollment
- 50
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\)No treatment with chemotherapeutics and radiation 2\)Simultaneous or metachronous double cancers 3\)Pregnant or lactating women or women of childbearing potential 4\)Other patients who are unfit for the study as determined by the attending physician
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 2
Randomized phase II/III study of 5-fluorouracil /l-leucovorin vs. 5-fluorouracil /l-leucovorin plus paclitaxel in gastric cancer with severe peritoneal metastasis (JCOG1108/WJOG7312G, abbreviation:GC_FL/FLTAX_P2/3)Gastric cancerJPRN-UMIN000010949Japan Clinical Oncology Group (JCOG)330
Completed
Not Applicable
Phase II randomized trial comparing 5-fluorouracil in continuous infusion and cisplatin (FP) versus leucovorin, bolus 5-fluorouracil and cisplatin (FLP) in metastatic gastric, pancreatic and oesophageal cancerMetastatic gastric, pancreatic and oesophageal cancerCancerOesophagealISRCTN05842222French Federation of Digestive Cancers (Fédération Francophone de la Cancérologie Digestive [FFCD]) (France)232
Completed
Phase 1
A phase I/II study of hepatic arterial 5-flurouracil (5FU) combined with intravenous irinotecan hydrochloride (CPT-11) for metastatic colorectal cancer isolated in the liver. (JCOG 0208-DI)Metastatic colorectal cancer isolated in the liverJPRN-C000000051Japan Clinical Oncology Group(JCOG)30
Active, not recruiting
Not Applicable
5-Fluorouracil in relapsed EpendymomaRecurrent or refractory ependymomaMedDRA version: 17.1Level: PTClassification code 10014967Term: EpendymomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Therapeutic area: Diseases [C] - Cancer [C04]EUCTR2014-001470-34-GBRoyal Marsden NHS Foundation Trust
Completed
Not Applicable
A randomised trial of infusional 5-fluorouracil and concomitant radiotherapy in locally advanced rectal cancer, comparing three and six months of infusional 5-fluorouracilCancer of rectumCancerISRCTN93845533The Royal Marsden NHS Foundation Trust (UK)